These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21421621)

  • 1. Serum interleukin 6 levels and cirrhosis-associated pulmonary hypertension.
    Kalambokis GN; Mouzaki A; Rodi M; Pappas K; Korantzopoulos P; Tsianos EV
    Angiology; 2011 May; 62(4):344-5. PubMed ID: 21421621
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts.
    Senior RM; Britton RC; Turino GM; Wood JA; Langer GA; Fishman AP
    Circulation; 1968 Jan; 37(1):88-96. PubMed ID: 5634734
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation.
    Pellicelli AM; Barbaro G; Puoti C; Guarascio P; Lusi EA; Bellis L; D'Ambrosio C; Villani R; Vennarecci G; Liotta G; Ettore G; Andreoli A
    Angiology; 2010 Nov; 61(8):802-6. PubMed ID: 20498147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary arterial hypertension disclosing liver cirrhosis].
    Squara P; Dahan M; Juliard JM; Ramond MJ; Fabiani B; Gourgon R
    Ann Med Interne (Paris); 1987; 138(5):377-8. PubMed ID: 3674614
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary pulmonary hypertension and cirrhosis: are they related?
    McDonnell PJ; Toye PA; Hutchins GM
    Am Rev Respir Dis; 1983 Apr; 127(4):437-41. PubMed ID: 6838050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.
    Humbert M; Monti G; Brenot F; Sitbon O; Portier A; Grangeot-Keros L; Duroux P; Galanaud P; Simonneau G; Emilie D
    Am J Respir Crit Care Med; 1995 May; 151(5):1628-31. PubMed ID: 7735624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension. Its association with hepatic cirrhosis and iron accumulation.
    Molden D; Abraham JL
    Arch Pathol Lab Med; 1982 Jul; 106(7):328-31. PubMed ID: 6896445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary vascular disorders in chronic diseases of the liver].
    Cadranel J; Cadranel JF
    Gastroenterol Clin Biol; 1994; 18(10):824-8. PubMed ID: 7875389
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation, COPD, and pulmonary hypertension.
    Hoeper MM; Welte T
    Chest; 2007 Feb; 131(2):634-5; author reply 635. PubMed ID: 17296674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the right heart and external respiratory functions in patients with liver cirrhosis by Doppler echocardiography].
    Maev IV; Merzlikin LA; Vorob'ev LP; Busarova GA
    Sov Med; 1991; (8):11-3. PubMed ID: 1763348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension complicating portal hypertension.
    Lebrec D; Capron JP; Dhumeaux D; Benhamou JP
    Am Rev Respir Dis; 1979 Oct; 120(4):849-56. PubMed ID: 159649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension.
    Selimovic N; Bergh CH; Andersson B; Sakiniene E; Carlsten H; Rundqvist B
    Eur Respir J; 2009 Sep; 34(3):662-8. PubMed ID: 19324949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension during the course of liver cirrhosis--presentation of two cases].
    Budzyński J; Pulkowski G; Swiatkowski M; Korenkiewicz J; Skok Z; Sujkowska R
    Pol Arch Med Wewn; 1997 Jun; 97(6):552-6. PubMed ID: 9441291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.
    Wiest R; Weigert J; Wanninger J; Neumeier M; Bauer S; Schmidhofer S; Farkas S; Scherer MN; Schäffler A; Schölmerich J; Buechler C
    Cytokine; 2011 Feb; 53(2):178-83. PubMed ID: 20637651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization Class III COPD-associated pulmonary hypertension: are we there yet in understanding the pathobiology of the disease?
    Steiner MK
    Chest; 2009 Sep; 136(3):658-659. PubMed ID: 19736185
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-6 in hepatitis C cirrhosis.
    Malaguarnera M; Trovato BA; Laurino A; Di Fazio I; Romeo MA; Motta M
    Panminerva Med; 1996 Dec; 38(4):207-10. PubMed ID: 9063027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
    Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
    Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author's replay.
    Silvestre OM; Farias AQ
    Ann Hepatol; 2013; 12(2):340. PubMed ID: 23745216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.